Obesity News

Advertisement
Medindia's Press Release’ section provides the latest press release on Obesity from across the world for the global audience. This page links to 515 Obesity press releases.

Obesity Action Coalition (OAC) Applauds Biden Administration's Efforts to Increase Access to Obesity Care

PR Newswire TAMPA, Fla., Aug. 29, 2024 TAMPA, Fla., Aug. 29, 2024 /PRNewswire/ -- The Obesity Action Coalition (OAC) commends the Biden Administration for raising awareness of the need to expand access to obesity care and reduce the high ...

Advertisement

First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity

PR Newswire CRANBURY, N.J., Aug. 22, 2024 CRANBURY, N.J., Aug. 22, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...

With Rise of GLP-1s, HealthEZ Provides Insights and Cost Containment Considerations and Solutions Related to Coverage for Obesity

PR Newswire BLOOMINGTON, Minn., Aug. 19, 2024 While the cost of these weight loss drug medications is high, HealthEZ notes employers could see long-term savings when coupled with smart weight loss behavioral programs — but a strong wellness ...

RedHill Announces Positive Obesity and Diabetes Results with Opaganib

PR Newswire TEL-AVIV, Israel and RALEIGH, N.C., Aug. 19, 2024 The global obesity-diabetes drugs market is projected to be worth around $100 billion by 2034[1] – largely driven by Glucagon-like peptide-1 (GLP-1) inhibitors like Novo Nordisk's ...

NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

PR Newswire CAMBRIDGE, Mass., Aug. 13, 2024 No Significant Issues Encountered During the Single Ascending Dose (SAD) Study, Allowing for Previously Reported Accelerated Start to Multiple Ascending Dose (MAD) Part 2 Top Line Data Readout ...

Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity

Sable Therapeutics, a portfolio company of Turret Capital Management, announces licensing agreement with Columbia University NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Sable Therapeutics, an innovative early stage drug development ...

NeuroBo Pharmaceuticals Announces Joint Research Agreement, Together with Dong-A ST and ImmunoForge to Develop a Long-Acting Once-Monthly Formulation of DA-1726 for the Treatment of Obesity

Collaboration to Leverage ImmunoForge's ELP Platform Technology Which Can Increase the Half-Life of a Drug by up to 200 Times CAMBRIDGE, Mass. , Aug. 6, 2024 /PRNewswire/ --   NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a ...

Revolutionary Fat Reduction Solution: Citrus Bottle Launches, Setting New Standards in Body Contouring

The Citrus Bottle introduces a sophisticated formula, including Riboflavin and Bromelain, designed to enhance fat metabolism and improve body contours efficiently. PARIS , Aug. 1, 2024 /PRNewswire-PRWeb/ -- Today marks the official ...

New Survey Shows Strong Patient Support for Personalized Obesity Interventions

Respondents ages 18 to 65 highlight urgency for medical recognition, scientifically proven interventions, and genetic testing for personalized obesity treatment. MENLO PARK, Calif. , Aug. 1, 2024 /PRNewswire/ --  Phenomix Sciences ...

DX&VX is on Track and Accelerating the Development of Oral Obesity Treatment

Confirmation of effects compared to global late-stage clinical trials Accelerating the development of obesity treatment through early licensing out, global joint clinical trials, research funding investment, etc. SEOUL, South Korea , ...

Advertisement
Advertisement

Obesity News »

Why Do We Crave Unhealthy Food? Is the Brain to Blame?

Why Do We Crave Unhealthy Food? Is the Brain to Blame?

Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.

Surge in Adolescent Overweight/Obesity in England

Surge in Adolescent Overweight/Obesity in England

Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.

Weight Loss Drugs Are Changing What We Eat and How We Buy

Weight Loss Drugs Are Changing What We Eat and How We Buy

The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.

Weight Loss Benefits Last, Even After Regaining Some Weight

Weight Loss Benefits Last, Even After Regaining Some Weight

Losing a lot of weight provides long-term health benefits, even if some weight is regained.

Active Childhood, Stronger Lungs: Childhood Obesity Raises COPD Risk!

Active Childhood, Stronger Lungs: Childhood Obesity Raises COPD Risk!

A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.

More Obesity News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement
Advertisement
Advertisement